Reproductive Biology / Medicine / Infertility MCQs – Exercise 18

The multiple choice questions in this online test paper focuses on Reproductive Biology / Reproductive Medicine / Infertility MCQ. If you are looking for self evaluation of your PG Medical entrance exam preparation then this online Reproductive Biology / Reproductive Medicine / Infertility MCQ Test Paper will help you to evaluate your exam preparation.

Instruction for REPRODUCTIVE BIOLOGY/ REPRODUCTIVE MEDICINE / INFERTILITY MCQs:

1- This online MCQ practice test paper contains 30 questions.
2- Each question in this online practice test paper have four options and only 1 option is correct.
3- You can view the answers of this practice test paper after submitting the practice test paper.
Note: The answers mentioned at the end of practice test are the best suitable option as per our knowledge. Users shall cross-check the answers with their textbooks.

Q 1. Amniotic fluid contains acetyl cholinesterase enzyme. What is the diagnosis ?

Open spina bifida

Gastrochisis

Omphalocele

Osteogenesis imperfect

Q 2. What criteria are used to determine if a maintenance dose of magnesium sulfate should be given?

A respiratory rate of more than 20/minute, patellar reflexes present, and urine output of more than 40 mL/hour

A respiratory rate of more than 16/minute, patellar reflexes present, and urine output of more than 30 mL/hour

A respiratory rate of more than 18/minute, patellar reflexes absent, and urine output of more than 20 mL/hour

None

Q 3. Increasing maternal weight is associated with

An increase in maternal serum AFP levels in the second trimester

An increase in maternal serum unconjugated oestriol levels in the second trimester

A decrease in maternal serum free beta-HCG levels in the second trimester

No change in maternal serum AFP levels in the second trimester

Q 4. Triple test should be done at weeks of gestation

12-14 weeks

14-16 weeks

16-18 weeks

18-20 weeks

Q 5. At term amniotic fluid volume is

800ml

500 ml

400 ml

600 ml

Q 6. Increased nuchal fold thickness is a feature of

Down syndrome

Dupan syndrome

Edward syndrome

Cri-du chat syndrome

Q 7. With reference to the combined screening test for Down’s syndrome false is

Measures nuchal transluscency

Measures free beta-HCG

Measures pregnancy-associated plasma protein A

Measures alpha feto-protein

Is undertaken at 11-14 weeks gestation

Q 8. The Triple test used to screen for Down’s syndrome

Should not be performed after 15 weeks gestation

Measures AFP, HCG and Inhibin-A

Measures AFP, HCG and oestrogen

Measures AFP, HCG and unconjugated oestriol

Q 9. Maternal serum inhibin-A levels

Decrease with increasing gestation age after 17 weeks

Are higher in women with a fetus affected by Down’s syndrome

Increase with increasing gestation age between 11 – 14 weeks

Are unaffected by fetal Down’s syndrome

Q 10. which one of the biochemical marker is most sensitive to detect open spina bifida

Maternal Serum alpha fetoprotein

Amniotic fluid alpha fetoprotein

Amniotic fluid acetyl cholinesterase

Amniotic fluid glucohexaminase

Q 11. Volume of amniotic fluid is maximum at what weeks of gestation

at term

32-36 weeks

28-32weeks

post term

Q 12. Maternal Serum alpha fetoprotein is elevated in all the following EXCEPT

Open spina bifida

Esophageal atresia

Post maturity

Bronchial aplasia

Q 13. Drug of choice in eclampsia:

Oral magnesium sulphate

Intravenous magnesium sulphate

Oral phenytoin sodium

Intravenous phenytoin sodium

Q 14. Triple test for Down syndrome include all except

Estriol

AFP

hCG

USG

Q 15. Alpha feto protein is increased in

Hepatoblastoma

Neuroblastoma

Seminoma

Down syndrome

Q 16. Between 11 – 14 weeks gestation

Maternal serum pregnancy associated plasma protein A levels are unchanged

Maternal serum pregnancy associated plasma protein A levels decrease

Maternal serum free beta-HCG levels are unchanged

Maternal serum free beta-HCG levels decrease

Q 17. Conception through IVF is associated with all except

An increased risk of Down’s syndrome

Higher rate of false positive screening for Down’s syndrome

Higher maternal serum free beta-HCG levels in the second trimester

Lower maternal serum unconjugated oestriol levels in the second trimester

Q 18. Principal carbohydrate present in Amniotic fluid ?

Glucose

Fructose

Mannose

Galactose

Q 19. Tuberculosis affects part of fallopian tube (in sequence)

Ampulla > isthmus>interstitial

isthmus>interstitial>ampulla

Ampulla>interstitial> isthmus

interstitial>ampulla>isthmus

Q 20. The Triple test used to screen for Down’s syndrome demonstrates

↓AFP, ↓HCG and ↓ unconjugated oestriol

↑ AFP, ↓HCG and ↓ unconjugated oestriol

↑ AFP, ↑HCG and ↓ unconjugated oestriol

↓AFP,↑HCG and ↓ unconjugated oestriol

Q 21. Which one is the most effective maternal serum marker for Down’s syndrome during the second trimester?

Unconjugated oestradiol

Unconjugated oestriol

Alpha-fetoprotein

Free beta-HCG

Q 22. Very low Maternal Serum alpha fetoprotein is seen in all except

Low birth infants

Miacariage

Still birth

all are false

Q 23. If a patient with severe preeclampsia does not have convulsions, when should birth take place?

Within 12 hours of the onset of symptoms

Within 24 hours of the onset of symptoms

Within 12 hours of admission to hospital

None

Q 24. Which one is used as part of first trimester screening for Down’s syndrome?

Maternal serum unconjugated oestriol

Maternal serum AFP

Maternal serum free beta-HCG

Maternal serum inhibin-A

Q 25. Which of the following is the most important step in managing severe preeclampsia

Quickly give antihypertensive

Call for help and give oxygen via face mask

Call for help and give loading dose of magnesium sulfate

None

Q 26. Which one of the statements regarding the Quadruple screening test for Down’s syndrome is not correct?

Undertaken at 11 – 14 weeks gestation

Measures maternal serum AFP

Measures maternal serum unconjugated oestriol

Measures maternal serum inhibin-A

Measures maternal serum free beta-HCG

Q 27. What is the correct loading dose of magnesium sulfate in preeclampsia?

4 g 20% IV slowly over 5 minutes and 5 g of 50% solution IM into each buttock

4 g 20% IV slowly over 20 minutes and 2 g of 50% solution IM into each buttock

4 g 50% IV slowly over 20 minutes and 5 g of 50% solution IM into one buttock

None

Q 28. Which one is used as part of second trimester biochemical screening for Down’s syndrome?

Maternal serum unconjugated oestradiol

Maternal serum unconjugated oestriol

Maternal serum oestradiol

Maternal serum conjugated oestriol

Q 29. If a patient with severe preeclampsia present with hematuria but maintaining urine output Delivered by cesarian section .retroplacental clot present treatment to prevent eclampsia in this patient

Pritchard regime (4 gm IV, 5 gm IM each buttock)

Low dose Magnessium sulphate therapy

Phenytoin 600 mg loading followed by 100 mg 8 hrly

Magnessium sulphate 1-2 gm/hour in a IV drip

Q 30. In normal pregnancies between 14 and 20 weeks gestation

Maternal serum AFP levels fall

Maternal serum unconjugated oestradiol levels fall

Maternal serum free beta-HCG levels fall

Maternal serum unconjugated oestradiol levels fall

Reproductive Biology / Medicine / Infertility MCQs – Exercise 18

pgmedmin

Recent Posts

Categories

Reproductive Biology / Medicine / Infertility MCQs – Exercise 18

pgmedmin

Popular Tags

Recent Posts

Categories